Cases & Deals

Hana Biosciences maintains patent portfolio for small molecule chemotherapeutic clinical candidate Talvesta™

Clients Hana Biosciences, Inc.

Jones Day managed Hana Biosciences' patent portfolio covering its small molecule chemotherapeutic clinical candidate Talvesta™ (talotrexin).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.